Another proof of this phenomenon was the observation that serum MtCK activities were significantly higher in patients with hepatocellular carcinoma (HCC) than in those without HCC or healthy subjects, a result of a higher metabolic state [26]. Here, CKMT2 is linked to hepatocellular carcinoma.